Miliani Katiuska, L'Hériteau François, Alfandari Serge, Arnaud Isabelle, Costa Yannick, Delière Elisabeth, Carbonne Anne, Astagneau Pascal
Regional Co-ordinating Centre for Nosocomial Infection Control (C-CLIN Paris-Nord), Paris, France.
J Antimicrob Chemother. 2008 Oct;62(4):823-9. doi: 10.1093/jac/dkn277. Epub 2008 Jul 25.
In France, antibiotic consumption (ABC) is dramatically high in parallel with the high rate of multidrug-resistant bacteria. For the last few years, a nationwide policy has been implemented at the national level to control and monitor ABC. Since 2002, surveillance networks have been set up with voluntary hospitals to evaluate the antibiotic policy and consumption. The present study was conducted to identify whether specific control measures of the antibiotic policy could reduce ABC in hospitals.
Based on the data from the Northern France surveillance system, local recommendations and antibiotic use were collected annually on a standardized questionnaire that had 21 items. ABC was expressed in defined daily doses (DDDs) per 1000 patient-days (PDs). The ABC indicator was the overall antibiotic consumption. A multivariate logistic regression analysis was performed using low (< or =75th percentile) and high (>75th percentile) ABC as the dependent variable.
A total of 83/111 hospitals were included in the study. In 75% of the hospitals, total ABC was < or =669.5 DDDs/1000 PDs. The less frequent practices were educational antibiotic programmes (17%), authorization from an antibiotic specialist for selected antibiotics (26%) and systematic reassessment of AB treatment after 72 h (27%). In the multivariate analysis, three variables remained significantly and independently associated (P < 0.05) with ABC: the type of hospital, the proportion of non-acute-care beds and the nominative delivery form as the only antibiotic control measure. Total ABC was lower in hospitals having a nominative delivery form, compared with hospitals not having it. Conversely, ABC was significantly higher in public teaching hospitals compared with non-teaching hospitals. Similarly, ABC was higher in hospitals with a lowest proportion (i.e. < or =25%) of non-acute-care beds compared with hospitals where this proportion was >25%.
Specific control measures could lower ABC. Sustained control efforts should focus on antibiotics with the highest potential for emerging bacterial resistance.
在法国,抗生素消耗量(ABC)极高,与此同时多重耐药菌的发生率也很高。在过去几年里,国家层面实施了一项全国性政策来控制和监测抗生素消耗量。自2002年以来,已与自愿参与的医院建立了监测网络,以评估抗生素政策和消耗量。本研究旨在确定抗生素政策的特定控制措施是否能降低医院的抗生素消耗量。
基于法国北部监测系统的数据,每年通过一份包含21项内容的标准化问卷收集当地建议和抗生素使用情况。抗生素消耗量以每1000患者日(PDs)的限定日剂量(DDDs)表示。ABC指标为总体抗生素消耗量。以低(≤第75百分位数)和高(>第75百分位数)ABC作为因变量进行多因素逻辑回归分析。
本研究共纳入了111家医院中的83家。75%的医院中,总ABC≤669.5 DDDs/1000 PDs。不太常见的做法是开展抗生素教育项目(17%)、选定抗生素需经抗生素专科医生授权(26%)以及72小时后对抗生素治疗进行系统重新评估(27%)。在多因素分析中,有三个变量与ABC仍存在显著且独立的关联(P<0.05):医院类型、非急症护理床位的比例以及作为唯一抗生素控制措施的记名给药形式。与没有记名给药形式的医院相比,采用记名给药形式的医院总ABC较低。相反,公立教学医院的ABC显著高于非教学医院。同样,非急症护理床位比例最低(即≤25%)的医院的ABC高于该比例>25%的医院。
特定控制措施可降低抗生素消耗量。持续的控制努力应聚焦于具有最高细菌耐药性出现潜力的抗生素。